Cochlear signals cautious optimism as new flagship implant boosts high-value sales amidst market headwinds

Australian cochlear implant maker highlights promising reception of its Nucleus Nexa System and strategic cost-cutting, but faces ongoing challenges in key markets and margins, impacting near-term growth prospects. Cochlear has used its latest earnings update to underline both the promise…













